Clinical Trial Update: Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety trial of elobixibat in chronic idiopathic constipation was terminated. Results were posted in October 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• Elobixibat (elobixibat)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: TERMINATED | Results posted: 2015-10-20